| 영문 | hemolytic disease of newborn | 한글 | 신생아용혈병 |
|---|---|---|---|
| 설명 | 신생아에서 적혈구가 비정상적으로 많이 파괴되는 병으로 태아적모구증(erythroblastosis fetalis)와 같은 뜻으로 쓰인다. 이것은 어머니에게서 생산된 신생아나 태아의 적혈구에 대한 항체가 태반을 건너와서 태아의 적혈구와 결합하여서 생기는 용혈성빈혈을 이르는 말. 즉 신생아나 태아의 적혈구의 항체가 어머니의 몸에서 생산이 되고 이것이 태반을 통해서 태아에게 넘어가서 태아의 적혈구와 결합을 하고 이 항체와 결합한 적혈구는 파괴가 되어서 빈혈이 생긴 것을 태아적모구증이라고 한다. 이것은 Rh 적모구증(Rh erythroblastosis)와 ABO 적모구증(ABO erythroblastosis)로 나눌 수가 있다. |
||
| 영문 | hemolytic anemia | 한글 | 용혈빈혈 |
|---|---|---|---|
| 설명 | 용혈빈혈이란 적혈구의 과도한 파괴에 의한 빈혈이다. 원래 120일 정도의 수명을 가지는 적혈구의 수명이 짧아지는 것이다. 여기에는 여러 가지 원인이 있을 수가 있는데 대표적인 원인으로는 적혈구에 대한 항체가 생기는 것(발작성야간혈색소뇨증)과 적혈구자체의 이상(유전성둥근적혈구증), 그리고 다른 질병에 의해서 2차적으로 생기는 것이 있다. |
||
| AHA | acetohydroxamic acid; acquired hemolytic anemia; acute hemolytic anemia; American Heart Association;... |
|---|---|
| MHD | maintenance hemodialysis; mean hemolytic dose; mental health department; minimum hemolytic dilution;... |
| MAHA | Micro-Angiopathic Hemolytic Anemia; PB상 Helmet Cell Thrombocytopenia중 MAHA유발 &nbs... |
| AHA | Autoimmune Hemolytic Anemia |
| AIHA | Auto-Immune Hemolytic Anemia |
| BHS | Beta-hemolytic streptococci |
|---|---|
| GBS | Group B beta hemolytic streptococci |
| CH 50 | Complement hemolytic activity |
| DHTR | Delayed hemolytic transfusion reaction |
| FS | Faecal streptococci |
| hemolytic anaemia | <disease, haematology> Anaemia resulting from reduced red cell survival time and haemolysis, either due to an intrinsic defect in the erythrocyte (hereditary spherocytosis or ellipsocytosis, enzyme defects, haemoglobinopathy) or an extrinsic damaging agent. For example autoantibody (autoimmune haemolytic anaemia), iso antibody, parasitic invasion of the cells (malaria), bacterial or chemical haemolysins, mechanical damage to erythrocytes. Origin: Gr. Haima = blood (18 Nov 1997) |
|---|---|
| alpha-streptococci | Streptococci that form a green variety of reduced haemoglobin in the area of the colony on a blood agar medium. (05 Mar 2000) |
| beta-haemolytic streptococci | Those that produce active haemolysins (O and S) which cause a zone of clear haemolysis on the blood agar medium in the area of the colony; beta-haemolytic streptococci are divided into groups (A to O) on the basis of cell wall C carbohydrate (see Lancefield classification); Group A (in the strains pathogenic for man) comprises more than 50 types (designated by Arabic numerals) determined by cell wall M protein, which seems to be associated closely with virulence and is produced chiefly by strains with matt or mucoid colonies, in contrast to nonvirulent, glossy colony-producing strains; other surface protein antigens such as R and T (T substance), and the nucleoprotein fraction (P substance) seem to be of less importance. The more than 20 extracellular substances elaborated by strains of beta-haemolytic streptococci include erythrogenic toxin (elaborated only by lysogenic strains), deoxyribonuclease (streptodornase), haemolysins (streptolysins O and S), hyaluronidase, and streptokinase. Synonym: haemolytic streptococci. (05 Mar 2000) |
| group A streptococci | A common bacteria that is the cause of strep throat, scarlet fever, impetigo, cellulitis-erysipelas, rheumatic fever, acute glomerular nephritis, endocarditis, and group A streptococcal necrotizing fasciitis. The prototype is Streptococcus pyogenes. (05 Mar 2000) |
| group B streptococci | A leading cause of a form of neonatal sepsis that has a 10-20% mortality rate and leaves a large number of survivors with brain damage. Also a leading cause of meningitis. (05 Mar 2000) |
| haemolytic streptococci | Those that produce active haemolysins (O and S) which cause a zone of clear haemolysis on the blood agar medium in the area of the colony; beta-haemolytic streptococci are divided into groups (A to O) on the basis of cell wall C carbohydrate (see Lancefield classification); Group A (in the strains pathogenic for man) comprises more than 50 types (designated by Arabic numerals) determined by cell wall M protein, which seems to be associated closely with virulence and is produced chiefly by strains with matt or mucoid colonies, in contrast to nonvirulent, glossy colony-producing strains; other surface protein antigens such as R and T (T substance), and the nucleoprotein fraction (P substance) seem to be of less importance. The more than 20 extracellular substances elaborated by strains of beta-haemolytic streptococci include erythrogenic toxin (elaborated only by lysogenic strains), deoxyribonuclease (streptodornase), haemolysins (streptolysins O and S), hyaluronidase, and streptokinase. Synonym: haemolytic streptococci. (05 Mar 2000) |
| streptococci | <bacteria, organism> A genus of bacteria that are gram-positive cocci, often occurring in chains of varying length. Some pathogenic species produce exotoxins. In man, streptococcal species are responsible for numerous infections such as scarlet fever, tonsillitis, erysipelas (skin infection), endocarditis, rheumatic fever, glomerulonephritis, impetigo, pneumonia, meningitis, pharyngitis, lymphadenitis and wound infections. Streptococcus pneumoniae is the main culprit in lobar and bronchopneumonia. Streptococci have anti-phagocytic components (hyaluronic acid rich capsule and M protein) and release various toxins streptolysins O and s, erythrogenic toxin) and enzymes streptokinase, streptodornase, hyaluronidase and proteinase. Haemolytic streptococci (viridans streptococci) produce limited haemolysis on blood agar, include Streptococcus mutans, Streptococcus salivarius and Streptococcus pneumoniae. Beta haemolytic streptococci, of which Streptococcus pyogenes is the only species, though there are many serotypes, produce a broad zone of almost complete haemolysis on blood agar as a result of streptolysin O and S release. Alpha streptococci are nonhaemolytic (e.g. Streptococcus faecalis). (30 Sep 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|